Positive Signs Out of CMS, But Many in Medtech Need to See More

article image
ARTICLE SUMMARY:

Officials at the agency that oversees Medicare policy are certainly talking the talk in support of medtech innovation, and they are starting to walk the walk with new policies attempting to make improvements to the coverage, coding, and payment landscape for new devices. It is still early days though, and those in industry dealing with reimbursement challenges on the ground say a cultural shift at CMS is still needed.

Words and policies that have come out of the US Centers for Medicare and Medicaid Services in recent months are leading some in industry to a cautious optimism that CMS is turning a corner toward support for early adoption of medtech innovation. Meanwhile, many working in the trenches to win proper coverage, coding, and payment for new technologies remain skeptical, pointing to a need for a cultural shift and resource enhancement at the Medicare agency.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.


Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite

Questions?

We're here to help! Please contact us at: